Study touts benefits of imaging agent regadenoson

12/3/2009 | (free registration)

A study of patients with end-stage renal disease found that regadenoson, a vasodilator stress myocardial perfusion imaging agent, is safe and tolerable and is comparable to adenosine. "Unlike adenosine, it can be safely employed in patients with moderate airway disease or asthma," the lead investigator said.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA